chevron_leftBack
As of 24 April 2025, Shenzhen YHLO Biotech Co., Ltd. has a market cap of $1.17B USD, ranking #7470 globally and #1938 in China. It ranks #710 in the Healthcare sector, and #77 in the Medical Devices industry.
Key Stats
Market Cap
$1.17BUSD
8.5B CNY
Enterprise Value
$1.2BUSD
8.72B CNY
Revenue (TTM)
$273.32MUSD
1.99B CNY
EBITDA (TTM)
$67.19MUSD
489.61M CNY
Net Income (TTM)
$41.4MUSD
301.67M CNY
EBITDA Margin
25%
Profit Margin
15%
PE Ratio
28.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Yongbo Song
open_in_new
Employees
1,759
Founded
2008
Website
szyhlo.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.6% | -0.3% | -11% | -4.1% | -25% | -34% |
Upcoming Earnings
Earnings Date
Fri, Apr 25
Tomorrow
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
688575
深圳市亚辉龙生物科技股份有限公司 Class A
ISIN: CNE100005204
Shares Out.:
Shares Outstanding:
570.427M1
Shares Float:
484.95M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
14.93 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Shenzhen YHLO Biotech Co., Ltd.
Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers automatic chemiluminescence immunoassay analyzers, chemiluminescent immunoassay analyzers, and iModule automatic immunoassay pipelines; and automatic immunofluorescence staining systems, automatic immunofluorescence analysis systems, automatic western blotting analyzers, auto automatic western blot analyzers, and automatic western blotting instruments. It also provides UNION new generation immune analyzers; dry fluorescence immunoassay analyzers, vision automatic dynamic ESR analyzers, and vision dynamic ESR analyzers; and automated sample processing systems and intelligent laboratory information systems, as well as antigen detection and test kits. Shenzhen YHLO Biotech Co., Ltd. was founded in 2008 and is headquartered in Shenzhen, China.
